Total Payments
$21,904
2024 Payments
$4,331
Companies
34
Transactions
801
Medicare Patients
4,381
Medicare Billing
$2.6M
Payment Breakdown by Category
Food & Beverage$21,117 (96.4%)
Consulting$710.00 (3.2%)
Education$76.74 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $21,117 | 796 | 96.4% |
| Consulting Fee | $710.00 | 1 | 3.2% |
| Education | $76.74 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $3,705 | 146 | $0 (2024) |
| ABBVIE INC. | $2,414 | 97 | $0 (2024) |
| Janssen Biotech, Inc. | $2,380 | 86 | $0 (2024) |
| UCB, Inc. | $1,875 | 74 | $0 (2024) |
| PFIZER INC. | $1,349 | 75 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $1,155 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,147 | 34 | $0 (2024) |
| Lilly USA, LLC | $1,111 | 41 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $1,110 | 23 | $0 (2024) |
| Celgene Corporation | $969.05 | 47 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,331 | 98 | Amgen Inc. ($945.68) |
| 2023 | $3,276 | 111 | Janssen Biotech, Inc. ($654.59) |
| 2022 | $2,552 | 91 | Amgen Inc. ($554.04) |
| 2021 | $2,140 | 103 | Janssen Biotech, Inc. ($768.57) |
| 2020 | $1,038 | 47 | GlaxoSmithKline, LLC. ($239.83) |
| 2019 | $2,744 | 120 | AbbVie, Inc. ($572.20) |
| 2018 | $2,535 | 107 | Horizon Pharma plc ($371.47) |
| 2017 | $3,289 | 124 | Celgene Corporation ($524.26) |
All Payment Transactions
801 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Dermatology | ||||||
| 12/11/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/04/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $25.44 | General |
| Category: Immunology | ||||||
| 12/03/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $31.14 | General |
| Category: Immunology | ||||||
| 11/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $32.17 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: Dermatology | ||||||
| 11/17/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $122.00 | General |
| Category: Immunology | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $123.59 | General |
| Category: Immunology | ||||||
| 11/16/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $123.25 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $124.42 | General |
| 11/05/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $24.50 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $32.08 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | Cash or cash equivalent | $104.68 | General |
| Category: Immunology | ||||||
| 10/10/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $54.99 | General |
| Category: Immunology | ||||||
| 10/01/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $31.81 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 973 | 117,354 | $3.1M | $697,013 |
| 2022 | 18 | 1,163 | 102,566 | $2.6M | $621,657 |
| 2021 | 21 | 1,130 | 89,638 | $2.4M | $668,765 |
| 2020 | 21 | 1,115 | 72,942 | $1.9M | $598,460 |
Total Patients
4,381
Total Services
382,500
Medicare Billing
$2.6M
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 20550 | Injection into tendon or ligament | Office | 2022 | 71 | 106 | $22,704 | $4,547 | 20.0% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2022 | 54 | 107 | $11,756 | $2,797 | 23.8% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 39 | 50 | $8,750 | $1,518 | 17.3% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 16 | 18 | $4,175 | $890.72 | 21.3% |
| 20600 | Aspiration and/or injection of fluid from small joint | Office | 2022 | 26 | 28 | $5,396 | $868.82 | 16.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 150 | 964 | $4,815 | $836.18 | 17.4% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 12 | 18 | $2,166 | $551.41 | 25.5% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 11 | 19 | $1,903 | $512.99 | 27.0% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2022 | 13 | 65 | $21,125 | $325.38 | 1.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 28 | 30 | $1,320 | $295.35 | 22.4% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 20 | 84,000 | $1.7M | $485,004 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 253 | 499 | $168,910 | $45,896 | 27.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 27 | 2,760 | $115,920 | $45,494 | 39.2% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 51 | 490 | $117,790 | $30,249 | 25.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 182 | 182 | $92,820 | $22,151 | 23.9% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 21 | 107 | $46,950 | $11,106 | 23.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 110 | 131 | $30,421 | $8,732 | 28.7% |
| 20550 | Injections of tendon sheath, ligament, or muscle membrane | Office | 2021 | 72 | 96 | $20,220 | $4,120 | 20.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 53 | 72 | $19,740 | $3,971 | 20.1% |
| 73130 | X-ray of hand, minimum of 3 views | Office | 2021 | 65 | 125 | $13,738 | $3,257 | 23.7% |
| 96415 | Infusion of chemotherapy into a vein | Office | 2021 | 12 | 96 | $9,204 | $2,143 | 23.3% |
| 73562 | X-ray of knee, 3 views | Office | 2021 | 25 | 40 | $4,806 | $1,189 | 24.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 16 | 16 | $3,640 | $911.20 | 25.0% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 124 | 784 | $3,920 | $785.94 | 20.0% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2021 | 16 | 21 | $3,705 | $694.06 | 18.7% |
About Dr. Joseph Martinez, MD
Dr. Joseph Martinez, MD is a Rheumatology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/10/2012. The National Provider Identifier (NPI) number assigned to this provider is 1588911382.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Martinez, MD has received a total of $21,904 in payments from pharmaceutical and medical device companies, with $4,331 received in 2024. These payments were reported across 801 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($21,117).
As a Medicare-enrolled provider, Martinez has provided services to 4,381 Medicare beneficiaries, totaling 382,500 services with total Medicare billing of $2.6M. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Austin, TX
- Active Since 08/10/2012
- Last Updated 10/30/2022
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1588911382
Products in Payments
- TREMFYA (Drug) $2,565
- Enbrel (Biological) $2,191
- Cimzia (Drug) $1,563
- RINVOQ (Biological) $1,223
- LUPKYNIS (Drug) $1,110
- TALTZ (Drug) $1,080
- XELJANZ (Drug) $879.25
- EVENITY (Biological) $827.68
- Otezla (Drug) $772.25
- REMICADE (Biological) $735.71
- COSENTYX (Biological) $625.53
- Humira (Biological) $601.35
- ORENCIA (Biological) $596.29
- BENLYSTA (Biological) $572.04
- COSENTYX (Drug) $501.70
- KRYSTEXXA (Biological) $449.70
- KEVZARA (Drug) $370.22
- Rasuvo (Drug) $332.61
- Bimzelx (Biological) $312.62
- Actemra (Biological) $302.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Austin
Dr. Robert Koval, Md, MD
Rheumatology — Payments: $67,062
Rheumatology $67,062
Paul Pickrell, Md, MD
Rheumatology — Payments: $29,321
Rheumatology $29,321
Dr. Louis Robinett, M.d, M.D
Rheumatology — Payments: $6,520
Rheumatology $6,520
Marco Lopez Velazquez, M.d, M.D
Rheumatology — Payments: $3,941
Rheumatology $3,941
Sonia Yousuf, Md, MD
Rheumatology — Payments: $2,974
Rheumatology $2,974
Dr. Samir Patel, M.d, M.D
Rheumatology — Payments: $1,565
Rheumatology $1,565